XML 46 R21.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Earnings Per Share Attributable to Cardinal Health, Inc. | 12 Months Ended
--- | ---
Jun. 30, 2024
Earnings Per Share [Abstract] |
Earnings Per Share Attributable to Cardinal Health, Inc. | 13. Earnings/(Loss) Per Share Attributable to Cardinal Health, Inc. The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:
(in millions, except per share amounts) | 2024 |  | 2023 |  | 2022
Net earnings/(loss) | $ | 853 |  |  | $ | 331 |  |  | $ | (937) |
Net earnings attributable to noncontrolling interest | (1) |  |  | (1) |  |  | (1) |
Net earnings/(loss) attributable to Cardinal Health, Inc. | $ | 852 |  |  | $ | 330 |  |  | $ | (938) |
Weighted-average common shares–basic | 245 |  |  | 261 |  |  | 279 |
Effect of dilutive securities: |  |  |  |  |
Employee stock options, restricted share units and performance share units | 2 |  |  | 1 |  |  | — |
Weighted-average common shares–diluted | 247 |  |  | 262 |  |  | 279 |
Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.: | $ | 3.48 |  |  | $ | 1.27 |  |  | $ | (3.37) |
Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.: | 3.45 |  |  | 1.26 |  |  | (3.37) |
The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive for fiscal 2024, 2023 and 2022 were 1 million, 2 million and 5 million, respectively. During fiscal 2022, there were 1 million potentially dilutive employee stock options, restricted share units and performance share units, not included in the computation of diluted loss per common share attributable to Cardinal Health, Inc. because their effect would be anti-dilutive as a result of the net loss for the fiscal year.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration